ewopharma: Recherche

1. Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

… an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB…

2. Shield Therapeutics and ewopharma sign Feraccru licence agreement for Switzerland

… a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical marketing company headquartered in Schaffhausen, Switzerland, are pleased to announce that they have entered…

3. Ewopharma and Eisai announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib)

… SCHAFFHAUSEN, SWITZERLAND and HATFIELD, UK, 26th March, 2020 – Ewopharma, a pharmaceutical marketing company and Eisai Europe Ltd., a leading global research and development-based pharmaceutical company are pleased to…

4. Ewopharma launches new Corporate Design

… new corporate design coincides with Ewopharma’s expanding role as the trusted partner for medical marketing and consumer health-brand management for Central Eastern Europe and Switzerland – from market…

5. Otsuka and Ewopharma join the fight against tuberculosis in Romania by launching Deltyba®

… TB). Ewopharma and Otsuka’s subsidiary, Otsuka Novel Products GmbH (ONPG), the European Union marketing authorisation holder for Deltyba, have signed a commercial agreement enabling Ewopharma’s Romanian…

6. Partenaires & Marques

…Propres marques Partenaires & Marques PARTENAIRES & MARQUES Nous sommes votre partenaire pour le marketing médical et la gestion de marque pour la santé grand public - de l'accès au marché à la…

7. Leadership

… affaires ANTONIO MANTARRO Directeur de la gestion des relations ANITA MATTLE Directrice du marketing & de la santé grand public ALAIN STAUB Président directeur général CONSEIL…

8. Ewopharma strengthens its oncology business

… Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of 1st…

9. Vision/Mission

…aux consommateurs en Suisse ainsi qu’en Europe centrale et orientale. Nos capacités d'accès au marché et de marketing à la pointe de la technologie nous permettent d'accéder à de nouveaux marchés grâce à des thérapies…

10. Cookie Policy

… us for purposes such as collecting information on user behaviour, demographics, or for personalising marketing or advertising messages to you based on your browsing on the internet. Details about the third…